Pharmacists' role in the care of patients with heart failure: Review and future evolution

Journal of Managed Care Pharmacy

Volumn 20, Issue 2, 2014, Pages 206-213

  Cheng, Judy W M ^a   Cooke Ariel, Hannah ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b Natural Standard   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; ASSISTED CIRCULATION; CLINICAL PHARMACY; COST EFFECTIVENESS ANALYSIS; DRUG DOSE TITRATION; DRUG INFUSION; FOLLOW UP; HEALTH CARE COST; HEART FAILURE; HOME CARE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; MEDLINE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PEER REVIEW; PHARMACEUTICAL CARE; PHARMACIST; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCISEARCH; SYSTEMATIC REVIEW (TOPIC);

HEART FAILURE; HUMANS; PATIENT CARE TEAM; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; UNITED STATES;

EID: 84893443771     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2014.20.2.206     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. Division for Heart Disease and Stroke Prevention. Heart failure fact sheet. July 26, 2013. Available at: http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_failure.htm. Accessed September 1, 2013.
2. Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M. Clinical service organization for heart failure. Cochrane Database Syst Rev. 2012;9:CD002752.
3. Christensen M, Lundh A. Medication review in hospitalized patients to reduce morbidity and mortality. Cochrane Database Syst Rev. 2013;2:CD008986.
4. Ryan R, Santesso N, Hill S, Lowe D, Kaufman C, Grimshaw J. Consumeroriented interventions for evidence-based prescribing and medicines use: an overview of systemic reviews. Cochrane Database Syst Rev. 2011;5:CD007768.
5. Eggink RN, Lenderink AW, Widdershoven JW, van den Bemt PM. The effect of a clinical pharmacist discharge service on medication discrepancies in patients with heart failure. Pharm World Sci. 2010;32(6):759-66.
6. Kripalani S, Roumie CL, Dalal AK, et al. Effect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial. Ann Intern Med. 2012;157(1):1-10.
7. Haynes KT, Oberne A, Cawthon C, Kripalani S. Pharmacists' recommendations to improve care transitions. Ann Pharmacother. 2012;46(9):1152-59.
8. Rodgers JE, Stough WG. Underutilization of evidence-based therapies in heart failure: the pharmacist's role. Pharmacotherapy. 2007;27(4 Pt 2):18S-28S.
9. Fonarow GC, Yancy CW, Heywood JT; ADHERE Scientific Advisory Committee, Study Group, and Investigators. Adherence to heart failure quality-of-care indicators in US hospitals: analysis of the ADHERE Registry. Arch Intern Med. 2005;165(13):1469-77.
10. Lee DS, Tu JV, Juurlink DN, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA. 2005;294(10):1240-47.
11. Jain A, Mills P, Nunn L, et al. Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents. Eur J Heart Fail. 2005;7(3):405-10.
12. Dobesh PP, Bosso J, Wortman S, et al. Critical pathways: the role of pharmacy today and tomorrow. Pharmacotherapy. 2006;26(9):1358-68.
13. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998; 158(10):1067-72.
14. Stewart S, Vandenbroek AJ, Pearson S, Horowitz JD. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med. 1999;159(3):257-61.
15. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract. 1995;49(4):173-76.
16. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19(7):860-69.
17. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159(16):1939-45.
18. Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999;56(13):1339-42.
19. Whellan DJ, Gaulden L, Gattis WA, et al. The benefit of implementing a heart failure disease management program. Arch Intern Med. 2001;161(18):2223-28.
20. Patel K, Sansgiry SS, Miller L. Pharmacist participation in home health heart failure programs. Am J Health Syst Pharm. 2003;60(21):2259-60.
21. Lowrie R, Mair FS, Greenlaw N, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012;33(3):314-24.
22. Gwadry-Sridhar FH, Arnold JM, Zhang Y, Brown JE, Marchiori G, Guyatt G. Pilot study to determine the impact of a multidisciplinary educational intervention in patients hospitalized with heart failure. Am Heart J. 2005;150(5):982.
23. López Cabezas C, Falces Salvador C, Cubí Quadrada D, et al. Randomized clinical trial of a postdischarge pharmaceutial care program vs regular followup in patients with heart failure. Farm Hosp. 2006;30(6):328-42.
24. Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart. 2005;91(7):899-906.
25. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT. Pharmacist care of patients with heart failure: a systematic review of randomized trials. Arch Intern Med. 2008;168(7):687-94.
26. Jennings DL, Brewer R, Smith C, Williams C. Clinical pharmacist intervention for patients with left ventricular assist devices. Ann Pharmacother. 2011;45(10):1311-12.
27. Ryder M, Murphy NF, McCaffrey D, O'Loughlin C, Ledwidge M, McDonald K. Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure. Eur J Heart Fail. 2008;10(3):267-72.
28. Milfred-LaForest SK, Chow SL, DiDomenico RJ, et al. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. Pharmacotherapy. 2013;33(5):529-48.